Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Julai 2026, 17:34:30
Obesity in adults
Obesity is a chronic, relapsing, multifactorial disease characterized by excessive accumulation of body fat that adversely affects health. It is associated with increased morbidity and mortality through its effects on the cardiovascular, endocrine, respiratory, musculoskeletal, and gastrointestinal systems. Obesity significantly increases the risk of type 2 diabetes mellitus, hypertension, dyslipidaemia, coronary artery disease, stroke, osteoarthritis, obstructive sleep apnoea, several cancers, and reduced quality of life.
Individuals living with obesity frequently experience social stigma, discrimination, depression, anxiety, and reduced self-esteem. Effective management requires long-term lifestyle modification, behavioural support, and when appropriate, pharmacological therapy or bariatric surgery.
Risk factors
Excess caloric intake
Physical inactivity
Sedentary lifestyle
Family history of obesity
Genetic predisposition
Increasing age
Obesogenic medications (e.g., corticosteroids, some antidepressants and antipsychotics)
Endocrine disorders (e.g., hypothyroidism, Cushing syndrome)
Poor sleep
Psychological disorders
Excess alcohol consumption
Socioeconomic and environmental factors
Pathophysiology
Obesity develops when energy intake consistently exceeds energy expenditure, resulting in excessive storage of triglycerides within adipose tissue. Progressive adipocyte enlargement and hyperplasia lead to chronic low-grade inflammation, insulin resistance, altered adipokine secretion, endothelial dysfunction, and metabolic abnormalities that increase the risk of cardiovascular disease, diabetes mellitus, fatty liver disease, and other obesity-related complications.
Clinical presentation
Many patients are asymptomatic initially and obesity is identified during routine assessment. Clinical features may include:
Progressive weight gain
Increased waist circumference
Reduced exercise tolerance
Shortness of breath on exertion
Excessive daytime sleepiness
Snoring or symptoms of obstructive sleep apnoea
Joint pain, particularly involving the knees and hips
Chronic back pain
Psychological distress, depression, anxiety, or reduced self-esteem
Diagnostic criteria
Obesity is diagnosed using body mass index (BMI):
BMI (kg/m²) | Classification |
<18.5 | Underweight |
18.5–24.9 | Normal weight |
25.0–29.9 | Overweight |
≥30 | Obesity |
Adults attending health facilities should have their:
Height measured
Weight measured
Waist circumference measured
at least once every year.
Patients should also be evaluated for obesity-related comorbidities including:
Hypertension
Type 2 diabetes or prediabetes
Dyslipidaemia
Elevated waist circumference
Non-alcoholic fatty liver disease
Cardiovascular disease
Investigations
Initial assessment should include:
Body mass index (BMI)
Waist circumference
Blood pressure
Fasting blood glucose or HbA1c
Lipid profile
Liver function tests (especially elevated liver enzymes suggesting fatty liver disease)
Assessment of diet and physical activity
Assessment of sleep disorders
Assessment of eating behaviours and mood disorders
Review of medications that may contribute to weight gain
Cardiovascular risk assessment
Management
Management aims to achieve sustained weight loss, improve metabolic health, reduce obesity-related complications, and improve quality of life.
Non-pharmacological treatment
Lifestyle modification remains the cornerstone of obesity management.
Weight loss targets
Aim to lose 5–10% of baseline body weight within 6 months.
A weight loss of approximately 0.5 kg per week is recommended.
Even a sustained weight loss of 3–5% significantly reduces triglycerides, blood glucose, HbA1c, and the risk of developing type 2 diabetes.
Greater weight loss further improves blood pressure, LDL cholesterol, HDL cholesterol, and reduces the need for antihypertensive, antidiabetic, and lipid-lowering medications.
Dietary management
Create an energy deficit through calorie restriction.
Recommended daily caloric intake:
Women: 1,200–1,500 kcal/day
Men: 1,500–1,800 kcal/day
Approximately 25–30 kcal/kg/day
Dietary recommendations include:
Approximately 20% of total energy from high-quality proteins such as lean meat and legumes.
Approximately 20% or less of total energy from fats.
Avoid saturated fats.
Restrict fried foods.
Choose low-fat dairy products.
Approximately 60% of total energy from complex carbohydrates.
Increase intake of whole grains, roots, tubers, vegetables, and fruits.
Limit sugars, honey, and refined carbohydrates.
Avoid alcohol because it provides excess calories with little nutritional value.
Avoid fad diets and unsustainable weight-loss practices.
Very-low-calorie diets (<800 kcal/day) should only be undertaken under medical supervision.
Physical activity
Begin with at least 30 minutes of moderate-intensity exercise 3–5 times per week.
Progress to at least 60 minutes on most days of the week.
Include muscle-strengthening activities on at least two days per week.
Encourage increased daily physical activity such as walking and stair climbing.
Behavioural interventions
Identify behaviours contributing to overeating and physical inactivity.
Set realistic, measurable lifestyle goals.
Maintain food, exercise, and weight records.
Eat breakfast regularly.
Maintain consistent eating patterns.
Encourage family involvement and social support.
Participate in structured lifestyle programmes for at least six months.
After successful weight loss, continue regular follow-up with maintenance programmes, monthly or more frequently, while maintaining 200–300 minutes of physical activity per week.
Referral
Refer patients to a specialist metabolic obesity clinic or bariatric surgery service when:
Weight loss of at least 5% has not been achieved after 3 months of comprehensive lifestyle intervention with or without pharmacotherapy.
BMI ≥40 kg/m².
BMI ≥35 kg/m² with obesity-related comorbidities despite optimal behavioural treatment.
Monitor medication requirements during weight loss, particularly antihypertensive and antidiabetic medicines, to prevent hypotension and hypoglycaemia.
Pharmacological treatment
Drug therapy may be considered in patients with:
BMI ≥30 kg/m².
BMI ≥27 kg/m² with obesity-related comorbidities.
Failure to lose approximately 0.5 kg per week after 3–6 months of lifestyle intervention.
Recommended medication:
Orlistat: 120 mg orally every 8 hours with each main meal containing fat (during the meal or within one hour after eating).
Treatment should be continued beyond 12 weeks only if at least 5% of the initial body weight has been lost since starting therapy and should always be used as an adjunct to lifestyle modification.
Innovative obesity care strategies
Primary care services should incorporate:
Electronic health records and patient registries.
Multidisciplinary care teams.
Evidence-based clinical decision support.
Text messaging and mobile health applications.
Remote monitoring of weight, blood pressure, and blood glucose.
Telephone and internet-based lifestyle support programmes.
Healthcare facilities should promote healthy environments by:
Providing healthy food choices.
Encouraging healthy beverage options.
Restricting fast-food outlets within hospital premises.
Supporting healthcare workers as role models for healthy lifestyles.
Complications
Type 2 diabetes mellitus
Hypertension
Dyslipidaemia
Coronary artery disease
Stroke
Heart failure
Pulmonary embolism
Obstructive sleep apnoea
Non-alcoholic fatty liver disease
Osteoarthritis
Chronic back pain
Gallbladder disease
Colorectal cancer
Reduced quality of life
Depression and anxiety
Premature mortality
Prognosis
Obesity is a chronic disease that requires lifelong management. Sustained lifestyle modification combined with behavioural support can achieve clinically meaningful weight loss and significantly reduce cardiovascular and metabolic risk. Pharmacotherapy and bariatric surgery may provide additional benefit in selected patients. Long-term success depends on continued adherence to healthy eating, regular physical activity, and ongoing clinical follow-up.
Prevention
Maintain a healthy balanced diet.
Engage in regular physical activity.
Avoid excessive caloric intake.
Limit consumption of sugar-sweetened beverages and processed foods.
Maintain a healthy body weight.
Screen adults annually using BMI and waist circumference.
Identify and manage obesity-related risk factors early.
Promote healthy lifestyles at individual, family, community, and healthcare facility levels.
Imeandikwa:
28 Julai 2026, 17:06:20
Rejea za mada hii:
Ministry of Health, United Republic of Tanzania. Tanzania Standard Treatment Guidelines and National Essential Medicines List (STG & NEMLIT), 2021.
World Health Organization (WHO). Obesity and overweight. Geneva: World Health Organization.
World Health Organization. WHO Guideline on the Prevention and Management of Obesity.
American Association of Clinical Endocrinology (AACE). Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity.
American Diabetes Association. Standards of Care in Diabetes.
Disclaimer: The information provided on this platform is for educational and informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Clinical recommendations are primarily based on the Tanzania Standard Treatment Guidelines and National Essential Medicines List (STG & NEMLIT), Seventh Edition, 2021, unless otherwise stated.
